• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; BIFURCATED STENT GRAFT Back to Search Results
Model Number BA25-100/I16-40
Device Problems Failure To Adhere Or Bond (1031); Stretched (1601)
Patient Problems Aneurysm (1708); Failure of Implant (1924); Rupture (2208)
Event Date 05/03/2018
Event Type  Injury  
Manufacturer Narrative
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.If additional information is obtained at a later time that is pertinent to this event, a follow-up report will then be submitted.
 
Event Description
Endologix became aware of an aortic rupture, abdominal aortic aneurysm growth (5cm to 10cm), and aortic neck dilation on (b)(6) 2018 as reported by physician (b)(6).The date of event is (b)(6) 2018 based on when the patient presented emergently with the rupture, reportedly due to follow-up negligence with no post-operative cta's.In addition, the physician believes that the inferior mesenteric artery (ima) t2 contributed to the aortic neck dilation.The patient was originally implanted with an afx bifurcated stent graft and vela suprarenal on (b)(6) 2014 by physician (b)(6) at (b)(6) medical center.During re-intervention, the patient was treated by implanting a medtronic thoracic cuff on (b)(6) 2018 by the reporting physician.The patient is doing well two weeks post-operative.
 
Manufacturer Narrative
A clinical evaluation of the reported event could not be completed due to a lack of receipt of relevant medical records and/or imaging.Requests were made on (b)(6) 2018 and the required records were not received.As such, event determination, off label conditions, related patient harms and patient disposition could not be independently assessed.The manufacturing lot review confirmed all devices met specifications prior to release.This complaint is not capa eligible at this time.These types of events will be monitored and trended as part of the quality system.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
MDR Report Key7565942
MDR Text Key109974232
Report Number2031527-2018-00515
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 05/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date12/31/2016
Device Model NumberBA25-100/I16-40
Device Lot Number1053291-024
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 05/22/2018
Initial Date FDA Received06/04/2018
Supplement Dates Manufacturer Received05/22/2018
Supplement Dates FDA Received08/10/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AFX-VELA SUPRARENAL - LOT 1210039-004; AFX-VELA SUPRARENAL - LOT 1210039-004
Patient Outcome(s) Required Intervention;
Patient Age62 YR
-
-